[1] |
Khan SA, Tomatsu SC. Mucolipidoses overview: past, present, and future[J]. Int J Mol Sci, 2020, 21(18): 6812. DOI: 10.3390/ijms21186812.
|
[2] |
Chen X, Qiu W, Ye J, et al. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China[J]. J Hum Genet. 2016, 61(4): 345-349. DOI: 10.1038/jhg.2015.155.
|
[3] |
Çelik B, Tomatsu SC, Tomatsu S, et al. Epidemiology of mucopolysaccharidoses update[J]. Diagnostics (Basel), 2021, 11(2): 273. DOI: 10.3390/diagnostics11020273.
|
[4] |
Lin HY, Lin SP, Chuang CK, et al. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004[J]. Am J Med Genet A, 2009, 149a(5): 960-964. DOI: 10.1002/ajmg.a.3278.
|
[5] |
Lin HY, Lee CL, Chang CY, et al. Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019)[J]. Orphanet J Rare Dis, 2020, 15(1): 314. DOI: 10.1186/s13023-020-01598-z.
|
[6] |
Gaffke L, Pierzynowska K, Podlacha M, et al. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases[J]. Cell Biol Int, 2021, 45(3): 498-506. DOI: 10.1002/cbin.11275.
|
[7] |
Stapleton M, Arunkumar N, Kubaski F, et al. Clinical presentation and diagnosis of mucopolysaccharidoses[J]. Mol Genet Metab, 2018, 125(1-2): 4-17. DOI: 10.1016/j.ymgme.2018.01.003.
|
[8] |
Mokhtariye A, Hagh-Nazari L, Varasteh AR, et al. Diagnostic methods for lysosomal storage disease[J]. Rep Biochem Mol Biol, 2019, 7(2): 119-128.
|
[9] |
Daitx VV, Mezzalira J, Goldim MP, et al. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma[J]. Clin Biochem, 2012, 45(15): 1233-1238. DOI: 10.1016/j.clinbiochem.2012.04.030.
|
[10] |
|
[11] |
Nybo M, Cadamuro J, Cornes MP, et al. Sample transportation-an overview[J]. Diagnosis (Berl), 2019, 6(1): 39-43. DOI: 10.1515/dx-2018-0051.
|
[12] |
|
[13] |
|
[14] |
Marsh J, Fensom AH. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease[J]. Clin Genet. 1985, 27(3): 258-262. DOI: 10.1111/j.1399-0004.1985.tb00217.x.
|
[15] |
|
[16] |
Giavarina D, Lippi G. Blood venous sample collection: recommendations overview and a checklist to improve quality[J]. Clin Biochem, 2017, 50(10-11): 568-573. DOI: 10.1016/j.clinbiochem.2017.02.021.
|
[17] |
Oemardien LF, Boer AM, Ruijter GJ, et al. Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots[J]. Mol Genet Metab, 2011, 102(1): 44-48. DOI: 10.1016/j.ymgme.2010.09.008.
|
[18] |
Archer IM, Harper PS, Wusteman FS. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome[J]. Clin Chim Acta. 1981, 112(1): 107-112. DOI: 10.1016/0009-8981(81)90274-6.
|
[19] |
Yi F, Hong X, Kumar AB, et al. Detection of mucopolysaccharidosis Ⅲ-A (Sanfilippo Syndrome-A) in dried blood spots (DBS) by tandem mass spectrometry[J]. Mol Genet Metab, 2018, 125(1-2): 59-63. DOI: 10.1016/j.ymgme.2018.05.005.
|
[20] |
Li D, Lin Y, Huang Y, et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis[J]. Prenat Diagn, 2018, 38(10): 779-787. DOI: 10.1002/pd.5329.
|
[21] |
Gelb MH, Lukacs Z, Ranieri E, et al. Newborn screening for lysosomal storage disorders: methodologies for measurement of enzymatic activities in dried blood spots[J]. Int J Neonatal Screen, 2019, 5(1): 1. DOI: 10.3390/ijns5010001.
|
[22] |
Wenger DA, Luzi P. The lysosomal diseases testing laboratory: a review of the past 47 years[J]. JIMD Rep, 2020, 54(1): 61-67. DOI: 10.1002/jmd2.12117.
|
[23] |
Baum H, Dodgson KS, Spencer B. The assay of arylsulphatases A and B in human urine[J]. Clin Chim Acta, 1959, 4(3): 453-455. DOI: 10.1016/0009-8981(59)90119-6.
|